Clinical oncology最新文献

筛选
英文 中文
Hypo-Fractionated Radiotherapy to the Cavity for Resected Brain Metastases: A UK Series 低分割腔放疗治疗脑转移瘤切除术:英国系列
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-22 DOI: 10.1016/j.clon.2025.103847
C.L. Barker , T. Shane , C. Hodgson , M. Jameson , J. King , P. Sanghera , S. Meade , R.J. Colaco , H. Benghiat
{"title":"Hypo-Fractionated Radiotherapy to the Cavity for Resected Brain Metastases: A UK Series","authors":"C.L. Barker ,&nbsp;T. Shane ,&nbsp;C. Hodgson ,&nbsp;M. Jameson ,&nbsp;J. King ,&nbsp;P. Sanghera ,&nbsp;S. Meade ,&nbsp;R.J. Colaco ,&nbsp;H. Benghiat","doi":"10.1016/j.clon.2025.103847","DOIUrl":"10.1016/j.clon.2025.103847","url":null,"abstract":"<div><h3>Aims</h3><div>With improved systemic disease control, the incidence of brain metastases in patients with cancer is increasing. Neurosurgical resection is recommended in selected cases, although local control following surgery remains an ongoing concern. Both fractionated radiotherapy and stereotactic radiosurgery (SRS) improve local control after surgical resection. Although postoperative SRS can avoid whole brain radiotherapy-associated toxicity, due to lack of survival and quality of life data, the optimum strategy remains debated. Furthermore, some cavities may be too large for SRS.</div></div><div><h3>Materials and methods</h3><div>In this multicentre study, patients following surgery for brain metastases were treated with a hypo-fractionated radiotherapy regimen (25Gy given in 5 fractions/30Gy in 6 fractions) to the surgical cavity.</div></div><div><h3>Results</h3><div>Sixty-five patients were identified from electronic patient notes with a median follow-up of 23.6 months (95% CI: 20.1–28.6). The 6-, 12-, 24- and 36-month freedom from local failure rates were 92.7% (95% CI: 81.7–97.2%), 77.3% (95% CI: 61.0–87.4%) and 70.6% (both 24- and 36-months, 95% CI: 52.9–82.5%), respectively. The 6-, 12- and 24-month overall survival rates were 80.0% (95% CI: 68.0–87.9%), 53.7% (95% CI: 40.6–65.2%) and 27.7% (95% CI: 16.0–40.7%), respectively. During follow-up, 10.8% (7/65 patients) developed leptomeningeal disease (LMD) and 3% (2/65 patients) developed radiation necrosis (RN). Treatment with hypo-fractionated radiotherapy to the surgical cavity was well tolerated; there was one episode of grade 3 toxicity (vomiting) in this patient cohort.</div></div><div><h3>Conclusion</h3><div>In this multicentre series of postoperative hypo-fractionated radiotherapy to the surgical cavity following resection of a brain metastasis, we demonstrated good rates of local control, with low risk of LMD and RN. Therefore, this radiotherapy regimen is a reasonable alternative to cavity SRS in patients with large cavity volumes or complete gross total resection within the UK. This should be investigated further within a prospective trial.</div></div>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"43 ","pages":"Article 103847"},"PeriodicalIF":3.2,"publicationDate":"2025-04-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"144190119","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Re-evaluating Adjuvant Therapy in Early-Stage Breast Cancer: Insights and Limitations From a Subtype Analysis 重新评估早期乳腺癌的辅助治疗:来自亚型分析的见解和局限性
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-18 DOI: 10.1016/j.clon.2025.103848
Q. Xu , Y. Gao
{"title":"Re-evaluating Adjuvant Therapy in Early-Stage Breast Cancer: Insights and Limitations From a Subtype Analysis","authors":"Q. Xu ,&nbsp;Y. Gao","doi":"10.1016/j.clon.2025.103848","DOIUrl":"10.1016/j.clon.2025.103848","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"43 ","pages":"Article 103848"},"PeriodicalIF":3.2,"publicationDate":"2025-04-18","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143947753","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A Single Centre Review of the Management of Testicular Sex Cord-Stromal Cell Tumours 睾丸性索间质细胞瘤治疗的单中心综述
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-16 DOI: 10.1016/j.clon.2025.103846
C. Thompson, Z. Rajan, A. Reid, S. Hazell, E. Mayer, D. Nicol, R. Huddart
{"title":"A Single Centre Review of the Management of Testicular Sex Cord-Stromal Cell Tumours","authors":"C. Thompson,&nbsp;Z. Rajan,&nbsp;A. Reid,&nbsp;S. Hazell,&nbsp;E. Mayer,&nbsp;D. Nicol,&nbsp;R. Huddart","doi":"10.1016/j.clon.2025.103846","DOIUrl":"10.1016/j.clon.2025.103846","url":null,"abstract":"<div><h3>Aims</h3><div>Sex cord stromal cell tumours (SCSCT) are a rare subset of testicular tumours, the majority of which are benign but a small proportion can be malignant. It has been demonstrated that certain histopathological risk factors can be useful in identifying those with malignant potential. However currently the absence of pathological risk factors is not used to exclude malignancy and this study aimed to investigate whether patients with one or fewer risk factors would relapse. We aim to confirm the hypothesis that no patient with one or fewer identified pathological risk factors predicting malignancy will develop metastatic disease.</div></div><div><h3>Materials and Methods</h3><div>This was a retrospective analysis of all patients from a single centre with a diagnosis of SCSCT over a 20-year period. Cases were reviewed for the presence or absence of risk factors. Relapse rates and overall survival between the groups with and without risk factors were compared using a Kaplan-Meier analysis.</div></div><div><h3>Results</h3><div>76 SCSCTs were identified, of which 56 were deemed low-risk due to the presence of one or fewer pathological risk factors predictive of malignancy. None of the 56 patients relapsed with metastatic disease and, when compared with the 20 patients who had 2 or more risk factors for malignancy, relapse rates were significantly higher (<em>p</em> &lt; 0.0001) and overall survival lower (<em>p</em> = 0.0003) in those who had risk factors. A key limitation is our sample size.</div></div><div><h3>Conclusion</h3><div>These findings, supported by the available literature on SCSCTs, suggest that malignancy can be accurately predicted based on pathological findings. There is potential that these findings can be used to tailor follow up of low-risk patients accordingly.</div></div>","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"42 ","pages":"Article 103846"},"PeriodicalIF":3.2,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143922843","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
RCR meetings 软的会议
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-16 DOI: 10.1016/S0936-6555(25)00099-8
{"title":"RCR meetings","authors":"","doi":"10.1016/S0936-6555(25)00099-8","DOIUrl":"10.1016/S0936-6555(25)00099-8","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"41 ","pages":"Article 103844"},"PeriodicalIF":3.2,"publicationDate":"2025-04-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143838448","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
An audit of non-NHS commissioning through evaluation-funded SABR for oligometastasis: a single-network study 通过评估资助的SABR对非nhs委托的低转移的审计:一项单一网络研究
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-14 DOI: 10.1016/j.clon.2025.103821
Rebecca Johnson , Philip Webb , Rebecca Muirhead
{"title":"An audit of non-NHS commissioning through evaluation-funded SABR for oligometastasis: a single-network study","authors":"Rebecca Johnson ,&nbsp;Philip Webb ,&nbsp;Rebecca Muirhead","doi":"10.1016/j.clon.2025.103821","DOIUrl":"10.1016/j.clon.2025.103821","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"40 ","pages":"Article 103821"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143830037","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Managing lower urinary tract symptoms (LUTS) during pelvic radiotherapy: a quality improvement project 盆腔放疗期间下尿路症状的管理:一个质量改善项目
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-14 DOI: 10.1016/j.clon.2025.103813
Christina Peters, Sally Appleyard
{"title":"Managing lower urinary tract symptoms (LUTS) during pelvic radiotherapy: a quality improvement project","authors":"Christina Peters,&nbsp;Sally Appleyard","doi":"10.1016/j.clon.2025.103813","DOIUrl":"10.1016/j.clon.2025.103813","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"40 ","pages":"Article 103813"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143830044","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cervical screening accessibility for healthcare staff: an improvement project at University Hospitals Bristol and Weston NHS Foundation Trust 保健人员的子宫颈检查可及性:布里斯托尔大学医院和韦斯顿国民保健服务基金会信托基金的改进项目
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-14 DOI: 10.1016/j.clon.2025.103815
Isabelle Wood, Miranda Worth, Eva Larkai, Hannah Compton, Amy Patel
{"title":"Cervical screening accessibility for healthcare staff: an improvement project at University Hospitals Bristol and Weston NHS Foundation Trust","authors":"Isabelle Wood,&nbsp;Miranda Worth,&nbsp;Eva Larkai,&nbsp;Hannah Compton,&nbsp;Amy Patel","doi":"10.1016/j.clon.2025.103815","DOIUrl":"10.1016/j.clon.2025.103815","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"40 ","pages":"Article 103815"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143830403","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Implementation of a cardio-oncology service for management of breast cancer patients on anti-HER2 treatment 为管理接受抗 HER2 治疗的乳腺癌患者提供肿瘤心脏病学服务
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-14 DOI: 10.1016/j.clon.2025.103816
John Boardman , Abigail Jenner , Richard Cassar-White , Iwan Harries , Thomas Strawson-Smith
{"title":"Implementation of a cardio-oncology service for management of breast cancer patients on anti-HER2 treatment","authors":"John Boardman ,&nbsp;Abigail Jenner ,&nbsp;Richard Cassar-White ,&nbsp;Iwan Harries ,&nbsp;Thomas Strawson-Smith","doi":"10.1016/j.clon.2025.103816","DOIUrl":"10.1016/j.clon.2025.103816","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"40 ","pages":"Article 103816"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143830388","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Evaluation and implementation of acute oncology service referral criteria: an evidence-based interdepartmental approach in a tertiary hospital in London 评估和实施急性肿瘤服务转诊标准:在伦敦三级医院的循证跨部门方法
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-14 DOI: 10.1016/j.clon.2025.103818
Matthew Lee, Joanna Meng, Maria Lourdes Valladolid, Alexandra Palmer Makowski, James Patrick, Akhila Wimalasingham
{"title":"Evaluation and implementation of acute oncology service referral criteria: an evidence-based interdepartmental approach in a tertiary hospital in London","authors":"Matthew Lee,&nbsp;Joanna Meng,&nbsp;Maria Lourdes Valladolid,&nbsp;Alexandra Palmer Makowski,&nbsp;James Patrick,&nbsp;Akhila Wimalasingham","doi":"10.1016/j.clon.2025.103818","DOIUrl":"10.1016/j.clon.2025.103818","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"40 ","pages":"Article 103818"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143828493","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Reductions of pelvic nodal planning target volume margins in cervix radiotherapy to improve bowel dose constraints 减少宫颈放射治疗中盆腔淋巴结规划靶体积边缘以改善肠剂量限制
IF 3.2 3区 医学
Clinical oncology Pub Date : 2025-04-14 DOI: 10.1016/j.clon.2025.103823
Justhna Motlib, Asma Sarwar, Gemma Eminowicz, Nicholas Venables, Helen Grimes
{"title":"Reductions of pelvic nodal planning target volume margins in cervix radiotherapy to improve bowel dose constraints","authors":"Justhna Motlib,&nbsp;Asma Sarwar,&nbsp;Gemma Eminowicz,&nbsp;Nicholas Venables,&nbsp;Helen Grimes","doi":"10.1016/j.clon.2025.103823","DOIUrl":"10.1016/j.clon.2025.103823","url":null,"abstract":"","PeriodicalId":10403,"journal":{"name":"Clinical oncology","volume":"40 ","pages":"Article 103823"},"PeriodicalIF":3.2,"publicationDate":"2025-04-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143830039","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信